Sensei Biotherapeutics logo

Sensei Biotherapeutics Share Price (NASDAQ: SNSE)

$7.78

-0.58

(-6.94%)

Last updated on

Check the interactive Sensei Biotherapeutics Stock chart to analyse performance

Sensei Biotherapeutics Inc Key Stats

Check Sensei Biotherapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$8.36
Open
$8.14
Market Capitalization
$10.5M
Today's Volume
$6.1K
Revenue TTM
$0.0
EBITDA
$-26.2M
Earnings Per Share (EPS)
$-21.29
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-67.47%

Stock Returns calculator for Sensei Biotherapeutics Stock including INR - Dollar returns

The Sensei Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Sensei Biotherapeutics investment value today

Current value as on today

₹69,476

Returns

₹30,524

(-30.52%)

Returns from Sensei Biotherapeutics Stock

₹35,809 (-35.81%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Sensei Biotherapeutics Stock

122%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Sensei Biotherapeutics Stock from India on INDmoney has increased by 122% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Sensei Biotherapeutics Inc

  • Name

    Holdings %

  • Vanguard Group Inc

    2.31%

  • Ikarian Capital, LLC

    1.78%

  • Catalio Capital Management, LP

    1.17%

  • Renaissance Technologies Corp

    0.70%

  • Geode Capital Management, LLC

    0.60%

  • BOOTHBAY FUND MANAGEMENT, LLC

    0.43%

Analyst Recommendation on Sensei Biotherapeutics Stock

Rating
Trend

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Sensei Biotherapeutics(by analysts ranked 0 to 5 stars)

Sensei Biotherapeutics Share Price Target

What analysts predicted

Upside of 317.74%

Target:

$32.50

Current:

$7.78

Sensei Biotherapeutics share price target is $32.50, a slight Upside of 317.74% compared to current price of $7.78 as per analysts' prediction.

Sensei Biotherapeutics Stock Insights

  • Price Movement

    In the last 7 days, SNSE stock has moved up by 5.0%
  • SNSE vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 100.9%
  • SNSE vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 190.7%

Sensei Biotherapeutics Technicals Summary

Sell

Neutral

Buy

Sensei Biotherapeutics is currently in a neutral trading position according to technical analysis indicators.

Sensei Biotherapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Sensei Biotherapeutics Inc logo
11.7%
-3.07%
-30.36%
-78.24%
-97.79%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Sensei Biotherapeutics Inc

Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. It also offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. It has a collaboration with The University of Washington to conduct preclinical studies for its solnerstotug program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
Organization
Sensei Biotherapeutics
Employees
14
CEO
Mr. John K. Celebi M.B.A.
Industry
Services

Key Management of Sensei Biotherapeutics Inc

NameTitle
Mr. John K. Celebi M.B.A.
President, CEO & Director
Dr. Edward Van der Horst Ph.D.
Chief Scientific Officer
Ms. Stephanie Krebs M.B.A., M.S.
Chief Business Officer
Mr. Josiah Craver
Senior VP of Finance, Principal Financial Officer & Principal Accounting Officer
Ms. Lora Pike
Vice President of Investor Relations & Communications
Mr. Christopher W. Gerry J.D.
Senior VP, General Counsel & Secretary
Dr. Aaron Weitzman FACP, M.D., Ph.D.
Chief Medical Officer

Important FAQs about investing in SNSE Stock from India :

What is Sensei Biotherapeutics share price today?

Sensei Biotherapeutics share price today is $7.78 as on at the close of the market. Sensei Biotherapeutics share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Sensei Biotherapeutics share?

Sensei Biotherapeutics share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Sensei Biotherapeutics stock price today i.e. is closed at $7.78, lower by 55.29% versus the 52 week high.

How to invest in Sensei Biotherapeutics Stock (SNSE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Sensei Biotherapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sensei Biotherapeutics Shares that will get you 0.1928 shares as per Sensei Biotherapeutics share price of $7.78 per share as on August 30, 2025 at 1:28 am IST.

What is the minimum amount required to buy Sensei Biotherapeutics Stock (SNSE) from India?

Indian investors can start investing in Sensei Biotherapeutics (SNSE) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Sensei Biotherapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Sensei Biotherapeutics share’s latest price of $7.78 as on August 30, 2025 at 1:28 am IST, you will get 1.2853 shares of Sensei Biotherapeutics. Learn more about fractional shares .

What are the returns that Sensei Biotherapeutics has given to Indian investors in the last 5 years?

Sensei Biotherapeutics stock has given -97.79% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?